Prevacid 24HR is owned by Perrigo (Ireland, NYSE: PRGO), which acquired the brand on 29 November 2019 for $61.5 million from GSK.[1][2]
Prevacid 24HR is a lansoprazole heartburn treatment sold over the counter in the United States, one of the proton pump inhibitors that moved off prescription in the 2000s. Perrigo acquired the American rights in 2020. These drugs suppress stomach acid production rather than neutralising it, which is why they work over days rather than minutes.
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Perrigo ownership tree →
Perrigo bought the branded over-the-counter rights to Prevacid 24HR from GlaxoSmithKline for $61.5 million in cash, capitalising $61.7 million including closing costs as a brand intangible and amortising it over twenty years. What changed hands was the right to sell the brand over the counter rather than the underlying drug, which is how most of Perrigo's branded portfolio has been assembled.
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
The parent company of Prevacid 24HR is Perrigo, a publicly listed company headquartered in Ireland.
Prevacid 24HR originated in the United States in 2009, but it is owned today by Perrigo, which is headquartered in Ireland. So Prevacid 24HR is an American-origin brand under Irish ownership.
Perrigo completed its acquisition of Prevacid 24HR on 29 November 2019. The deal was valued at $61.5 million (enterprise value).
Yes. As of 16 September 2026, Prevacid 24HR is still owned by Perrigo. The ownership record was last checked against primary sources on that date.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.